Restriction deoxyribonucleic acid (DNA) fragment profile analysis coupled with immunogenic protein profile analysis has provided useful information in determining the differences between vaccine strains and field isolates of fowlpox virus (FPV). The DNA of strains examined in this study clearly fell into 3 minor groups of restriction patterns similar but distinct from one another: restriction patterns exhibited by the vaccine strains except 1 vaccine strain, Vac-82; restriction profiles indicated by Vac-82 and field isolates FI-38 and FI-42; and restriction patterns indicated by field isolates FI-43, FI-51, FI-54, and FI-56. Furthermore, when the strains were analyzed and compared by immunoblotting analysis, they showed group differences similar to the differences in restriction profiles. Both techniques provided high sensitivity in verifying differences between vaccine strains and field isolates of FPV. The disparity found in restriction fragments or immunogenic protein profile between vaccine strains and field isolates does not exclude the appreciable high degree of DNA sequence conservation and homology. However, the minor disparity observed in these strains suggests a molecular basis for why vaccinated commercial flocks could have continually been infected by variant strains of FPV. A rapid and sensitive polymerase chain reaction method, which amplified a product from the 4b core protein gene of the FPV genome, was developed for identification and differentiation of members of the genus Avipoxvirus. Whereas total DNA from either vaccine strains or field isolates was used as template for amplifying a predicted product of 578 or 1409 bp, only cleavage of the amplified product (1409 bp) represented an additional detection technique for species differentiation. An attempt to distinguish between strains on the basis of amplification product was partially successful.
Commercial poultry have traditionally been protected against avian poxviruses with live, attenuated vaccines prepared with fowl poxvirus or pigeon poxvirus (PPV). These vaccines have reduced economic losses (Tripathy, DN: 1993, Outbreaks of fowl pox in vaccinated flocks. Proc of the 44th NC Av Dis Conf and Symp on Poultry Therapeutics pp. 93-94), although poxvirus infections have increasingly been reported in vaccinated commercial flocks (Fatunmbi O, Reed WM: 1993, Use of a bivalent vaccine in the control of avian pox in chickens. Proc 44th NC Av Dis Conf Symp Poult Ther pp. 94-95). These infections have been attributed to the emergence of ''variant'' strains that might be antigenically different from the vaccine virus 8 or to the appearance of previously unrecognized poxvirus strains. 6 There is some evidence that there is heterogeneity of avian poxviruses 20 and that chickens vaccinated with commercial fowl or pigeon pox vaccines are susceptible to infection with poxvirus of other avian species. On the basis of crossprotection studies, 7 neither a commercial quail pox vaccine nor a commercial modified live FPV vaccine conferred adequate protection to chickens against chal-From the Avian Disease Research Laboratory (Tadese) and Department of Pathobiology and Diagnostic Investigation (Reed), Michigan State University, East Lansing, MI 48824. lenge with variant poxvirus isolates from vaccinated chickens. Although such studies have been helpful in the evaluation of the efficacy of the vaccines and offer a method by which field strains can be distinguished, they do not point to genetic differences. Avian poxvirus infection has also been characterized by serologic tests, such as the agar gel precipitation test and passive hemagglutination. These detection methods have considerable limitations because of cross-reactions and cannot differentiate serologic responses of different species or strains of poxvirus. Restriction fragment length polymorphism (RFLP) has been widely used in the comparison and differentiation of the genus Orthopoxvirus 4, 5, 13, 15 and the genus Parapoxvirus, 14, 17, 21, 22 but its use has been described in only 2 studies of the genus Avipoxvirus, 9, 18 which involved very few isolates. Similarly, polymerase chain reaction (PCR) has been one of the most extensively applied techniques in the differentiation of various species and strains of viruses [10] [11] [12] but has very limited use for the characterization of viruses belonging to the genus Avipoxvirus.
In this study, the usefulness of 2 established techniques for the identification and differentiation of vaccine and field strains of FPV is reported. Furthermore, this report describes experience with the use of PCR on samples to evaluate its efficiency as a routine di- 
Materials and methods
Virus growth and purification. The sources of the vaccine strains and the field isolates of FPV included in the study are shown in Table 1 . Three other species, namely, turkey poxvirus (TPV), pigeon poxvirus, PPV, and quail poxvirus (QPV) were also included for comparison using the PCR technique only. The vaccine strains and field isolates were designated code numbers, with an abbreviation, Vac, for vaccine, and FI, for field isolate, placed before the numbers. All viruses were grown in primary chicken embryo fibroblast cell cultures prepared by trypsinization of 10-day-old specific-pathogen-free a chicken embryos. Cells were grown in Leibovitz McCoy medium b supplemented with 5% calf serum, 0.22% sodium bicarbonate, 0.24% HEPES, and 100 units/ml penicillin-streptomycin. b Cells were harvested from infected cultures with almost 90% cytopathic effect. After a series of freeze-thaw cycles, infected cells were centrifuged at 551 ϫ g for 10 min. The supernatant was pelleted at 21,525 ϫ g for 60 min at 4 C. The suspended pellet was sonicated c to 6 cycles, for 15 sec, and placed on ice for 40 sec between each cycle. The sonicated resuspension was centrifuged through a 9-ml cushion of 36% (wt/vol) sucrose at 31,000 ϫ g for 90 min at 4 C. The pellet was resuspended in TE (10 mM Tris-1 mM EDTA) of pH 9.0 and sonicated again to 2 cycles. The resulting resuspended pellet was layered on a 20%-50% (wt/vol) continuous sucrose gradient and centrifuged at 31,000 ϫ g for 60 min at 4 C. The band containing the purified virus particles was collected and pelleted by centrifuging at 86,100 ϫ g for 60 min at 4 C. The pellet was then resuspended in TE and stored at Ϫ80 C. Virus suspensions were also purified by sodium diatrizoate gradient centrifugation. 5 Viral DNA isolation. Viral DNA was isolated from infected cell monolayers as described. 3 In brief, infected cells were clarified by centrifugation, 551 ϫ g for 10 min. The supernatants were centrifuged at 21,525 ϫ g for 60 min, and the pellets were resuspended in TE. The resuspended pellets were further suspended in 0.5% 2-mercaptoethanol (2-ME) and 10% Triton X-100. The suspension was agitated on ice for 10 min and centrifuged at 1,240 ϫ g for 5 min; the resulting supernatant was centrifuged at 31,000 ϫ g for 60 min at 4 C. The pellet was reconstituted in TE buffer containing; 0.25% 2-ME, Proteinase K (10 mg/ml) and 20% Nlauryl sarcosinate. After 30 min of agitation on ice, 54% of sucrose in water and 20% sodium dodecyl sulfate (SDS) were added and incubated at 55 C for 2 hr. The resulting mixtures were extracted twice with 25:24:1 (vol/vol) phenol: chloroform:isoamyl alcohol and once with 24:1 (vol/vol) chloroform:isoamyl alcohol and concentrated by ethanol precipitation.
Restriction digestion and electrophoresis of DNA. Viral DNA was digested with EcoR I, Hind III, Bam H I, and Pst I according to the manufacturer's specifications. d Digested DNA was electrophoresed in either 0.7% or 1.2% agarose e gels (15 ϫ 15 cm) in 1ϫ 89 mM Tris-borate-89 mM boric acid-2 mM EDTA (TBE) containing ethidium bromide (0.5 g/ml) at 25 V for 16 hr using a DNA subcell gel apparatus. f Molecular size (ms) of restricted DNA fragments of strains were obtained by comparing electrophoretic migration of DNA fragments with those of lambda Hind III DNA fragment markers. b Initially, a standard curve for marker DNA was generated on a computer by plotting the ms versus the mobility of each known standard DNA, and simple linear equations were constructed from which the apparent ms were obtained by extrapolating the migration of the unknown DNA fragments.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting. Purified virus suspensions were solubilized in equal volumes of lysis buffer (50 mM Tris-HCl, pH 6.8; 5% 2-ME; 10% glycerol; 1% SDS; 0.001% bromophenol blue) and heated in a microwave oven (power output 725 W) for 60 sec. Supernatant extract from uninfected cells was also prepared and used as control. The protein concentrations of purified virus particles were determined photometrically using a protein assay kit, f and samples of equal protein concentrations were loaded in a stacking gel of 4% polyacrylamide and a resolving gel of 12% polyacrylamide. After 1 hr of electrophoresis at 120 V and 4 hr at 200 V, proteins on the gel were transferred to nitro- cellulose filters. f The filters were blocked with 5% nonfat dry milk in phosphate-buffered saline (PBS), pH 7.4, washed 4 times with PBS, and made to react with 1:200 chicken anti-FPV serum for 24 hr at room temperature. After washing 4 times with 0.02% Tween-20 in PBS, peroxidase g -labeled goat anti-chicken IgG (1:2,000) was added, and incubation was performed for 2 hr at room temperature. Following 4 washes with PBS, the filters were exposed to 4chloro-1-naphtol, as substrate, g containing 0.02% hydrogen peroxide. The relative molecular mass (rmm) of the reacted proteins was determined by comparison with protein standards. f PCR amplification. Oligonucleotide primers were designed using a computer program and synthesized at the macromolecular structure facility of the Department of Biochemistry, Michigan State University. Primers were designed on the basis of published DNA sequences of the 4b gene sequence of FPV (HP444). 1, 19 The primer sequence for the upper and lower oligonucleotides from 5Ј to 3Ј were as follows.
Core The reaction mixture was subjected to 35 amplification cycles. Each cycle consisted of a hot start at 94 C for 7 min, denaturation at 94 C for 30 sec, annealing at 50 C for 60 sec, extension at 72 C for 2 min, and final extension at 72 C for 7 min. PCR products were separated on 1.2% agarose gel in 1ϫ TBE. Amplification products were digested with EcoR V or Nla III and analyzed on 2% agarose gel.
Results
Restriction endonucleases analysis of DNA. The method of obtaining fragment sizes on the basis of simple linear equations provided an accurate estimate of the apparent ms of restricted DNA fragments. The restriction DNA fragment pattern of vaccine strains and field isolates after digestion with endonucleases Hind III or EcoR I is shown in Figs. 1, 2 . The DNA fragment pattern following Hind III digestion revealed subtle and minor differences that allowed differentiation of the vaccine strains and field isolates. Restriction fragment length polymorphism analysis revealed that 95% to 98% of DNA fragments were shared among the vaccine strains and field isolates. Approximately 2% to 5% of the fragments observed in the vaccine strains were absent or replaced by unique fragments in the field isolates. The vaccine strains showed an almost identical restriction pattern, with the exception of the Vac-82 strain, which could be distinguished because of the lack of fragments of ms 23, 5.9, 3.8, and 2.0 kb but possessed unique fragments with ms of 4.2, 3.3, and 2.7 kb (Fig. 1, lane 8) . Another vaccine strain, Vac-62, also had a unique fragment of ms 3.4 kb (Fig.  1, lane 4) . When the field isolates were compared with one another using the same restriction enzyme, similar restriction profiles were apparent, except with FI-38, which differed because of a lack of fragments of ms 23, 5.9, 3.8, and 2.0 kb (Fig. 1, lane 9) . Interestingly, unique fragments that were similar to Vac-82 were also detected in FI-38, suggesting that these 2 strains were much more closely related. Essentially, the same results were obtained from analysis of the restriction profile of strains with EcoR I. Approximately 95% of fragments were conserved among vaccine strains and field isolates. Again, Vac-82 and FI-38 could be differentiated because of the possession of unique fragments with ms of 8.7, 6.6, 4.6, and 3.4 kb (Fig. 2,   lanes 9 and 10) , absent in all the other vaccine strains. However, restriction DNA fragments of 8.7 and 4.6 kb ms were also present in the other field isolates. Restricted DNA fragments generated by Bam H I or Pst I were relatively few. Nevertheless, both enzymes yielded patterns that grouped the strains with Hind III and EcoR I. Bam H I digestion revealed that a high proportion of the restriction fragments was shared among vaccine strains and field isolates. Restriction fragments of ms 17.6, 5.7, 3.7, and 3.6 kb were uniquely found in Vac-82, FI-38, and FI-42; of these only the 17.6 kb fragment was shared by the other field isolates (data not included). Digestion of viral DNA with Pst I generated unique fragments of size 25.7, 4.3, 4.1, and 3.7 kb in only Vac-82, FI-38, and FI-42, but the 25.7-kb fragment was missing in FI-42. The restriction DNA fragment analysis of FPV strains following digestion with Hind III or EcoR I is summarized in Table 2 .
Immunoblotting analysis of antigens. To compare the immunogenic proteins among vaccine strains and field isolates of FPV, purified virus suspensions were first standardized and after electrophoresis on poly- 
* FPV ϭ fowlpox virus; DNA ϭ deoxy ribonucleic acid; ϩ ϭ presence of a specific restriction DNA fragment; Ϫ# ϭ absence of a specific DNA fragment.
acrylamide and transfer to nitrocellulose filters, immunoblotted using 3 different types of antisera: chicken anti-FPV serum prepared against a vaccine strain, chicken anti-FPV serum against a field isolate, and chicken anti-QPV serum. When antiserum against a vaccine strain was used, common antigens were detected, but uncommon ones were also identified in some of the strains. Antigens of rmm 63.5, 57.8, 48.4, 46.2, 42.4, 40.1, 26.8, and 18.7 kD were shared by all strains. This difference was reflected by the fact that some strains reacted with specific antigens, whereas others did not. As many as 18 immunogenic proteins with similar molecular mass were detected in each vaccine strain, with the exception of Vac-82, which had a smaller number of shared antigens. However, unique antigens with rmm of 53.5, 34.5, 14.4, and 12.8 kD were detected in Vac-82 (Fig. 3, lane 7) ; all of these were shared with FI-38 and FI-42 ( Fig. 3, lanes  8 and 9) . The antigen of rmm 34.5 kD was shared with FI-43, FI-51, and FI-56 ( Fig. 3, lanes 10, 11, and  13 ), but the antigen of rmm 53.5 kD was shared only with FI-43 and FI-51 ( Fig. 3, lanes 10 and 11) . In comparison with the total number of antigens identified in vaccine strains, fewer antigens were identifiable in FI-43, FI-51, FI-54, and FI-56; but only about 14 of these antigens occurred in FI-38 and FI-42. Relative to shared and unique antigens, Vac-82, FI-38, and FI-42 were much more closely related with one another. FI-43, FI-51, FI-54, and FI-56 exhibited a similar antigen profile; nonetheless, they appeared to share more antigens with the vaccine strains than with FI-38, FI-42, and Vac-82. A supernatant from uninfected cell culture did not react with antisera, and no antigens were detected (Fig. 3, lane 14) . When antiserum against a field isolate and FPV was used, the difference in protein profiles between the vaccine strains and field isolates was evident when antisera against the vaccine strain was used, except that more antigens from Vac-82, FI-38, and FI-42 reacted with the antiserum prepared against the field isolate, which may be attributable to increased specificity of the antisera. Antigens with rmm of 88.2, 24.3, and 11.9 kD were detected only in Vac-82, FI-38, and FI-42 ( Fig. 4, lanes 7, 8  and 9 ). Antigen profiles were distinctly different when a heterologous antiserum raised against a QPV was used. While Vac-82, FI-38, and FI-42 appeared to have almost identical profiles, the number of total antigens identified was much lower in almost all strains compared with when the homologous antisera were used. Antigens with rmm of 60.5, 34.8, and 29.4 kD were common to all strains examined (data not included). Antigens with rmm of 65, 39.3, 30.8, 25.2, 20, and 14.9 kD were only detected in Vac-82, FI-38, and FI-42, but antigens of rmm 65 and 39.3 kDa were also shared with the other field isolates. When normal chicken serum was used in the immunoblotting procedure, no antigens were detected in any of the virus strains. Table 3 summarizes the antigen profile analysis of the vaccine strains and field isolates of FPV.
PCR analysis of strains. A primer set designed from the 4b core protein gene of FPV amplified a 578-bp product in all virus strains (Fig. 5 ). There was no size difference of the amplified products. There was no amplification in control samples, e.g., DNA from chicken fibroblast cells or lambda DNA samples using any of the primers. Another set of primers from the same 4b 
* FPV ϭ fowlpox virus; ϩ ϭ presence of a specific antigen; Ϫ# ϭ absence of a specific antigen. core protein gene was designed, with the advantage that spanning the size of this target sequence may increase the sensitivity for differentiating strains. All vaccine and field strains amplified the predicted fragment of 1,409 bp but without apparent size distinction among strains. PCR fragments of 578 and 1,409 bp, from all strains and from TPV, PPV, and QPV were digested by EcoR V or Nla III restriction enzymes. Polymorphism in restriction patterns was only observed among FPV, TPV, PPV, and QPV with the 1,409-bp fragment but not with the 578-bp fragment. For example, after EcoR V digestion of the 1,409-bp, a vaccine strain of FPV could be differentiated from TPV and PPV. A 300-bp fragment was absent in FPV ( Fig. 6 ) but present in TPV and PPV. A 100-bp fragment is present in FPV but absent in both TPV and PPV. Similarly, after digestion of the 1,409-bp fragment with Nla III, the QPV strain could be differentiated from the other strains by the absence of both 220-and 200-bp fragments ( Fig. 7 ) but presence of a 150-bp fragment that is absent in FPV, TPV, and PPV. The sensitivity of PCR for amplification was determined by a serial dilution of purified genomic DNA and from nonpurified lysate supernatants of infected cultures. It was found that the highest dilution of 1: 1,000, which was equivalent to 500 ng, directly from lysate supernatant, amplified the expected product. However, about 200 ng of purified DNA was required to amplify the expected product.
Discussion
This work demonstrates minor genetic and antigenic differences between vaccine and field strains of FPV. Restriction analysis has been used to distinguish strains because a single base change in a recognition sequence of DNA could also result in a restriction fragmentation pattern. 15 Approximately 95% to 98% similarity in restriction fragment profiles was found among the vaccine strains and field isolates of poxvirus. However, 1 vaccine strain, Vac-82, and 2 field isolates, FI-38 and FI-42, demonstrated almost 99% to 100% similarity with one another. To determine the extent to which such homology observed in the DNA of these strains correlates with immunogenicity, viral immunogenic proteins were compared by immunoblot analysis using homologous and heterologous antisera. It has been reported that changes in the less conserved region of viral DNA results in differences in polypep-tides. 16 The results of antigen profile analysis demonstrated a positive correlation with the results of restriction analysis of these strains. A high degree of antigenic relatedness was indicated between the field isolates and vaccine strains, although strain differences were evident because common antigens were detected in nearly all strains, concomitant with unique antigens being present in only a few strains. Common antigens of approximately similar molecular mass were also identified in FPV vaccine strains, 18 but the sources of the strains used in this study were not the same. The difference in restriction and antigen patterns observed between vaccine strains and field isolates is not unexpected because differences in these strains have also been shown in cross-protection studies. 7 However, the high degree of genetic and antigenic relatedness observed among Vac-82, FI-38, and FI-42 is surprising because Vac-82 is a vaccine strain, whereas FI-38 and FI-42 are field isolates. Furthermore, FI-38 and FI-42 were shown to be biologically different 6 despite their high genetic and antigenic relatedness, albeit such a difference may be attributed to the almost 1% difference observed between them. At this point, whether FI-38 and FI-42 could possibly have evolved from Vac-82 remains a conjecture, and the situation is confounded even further by the lack of information regarding the source of fowlpox vaccine used to vaccinate the flock from which FI-38 and FI-42 were isolated. Recently, a poxvirus field isolate that was similar to a fowlpox vaccine has been identified. 2 The use of PCR for detection and differentiation of FPV is relatively new. Two problems presented themselves in the use of PCR for differentiation of FPV strains. First, there was no universal pair of primers to ensure PCR amplification for differentiating these viruses. Second, there was no total sequence of the FPV genome from which a suitable primer pair could be selected when this research was undertaken. Therefore, sets of primers were arbitrarily designed on the basis of the published partial gene sequences of FPV. The 4b core protein gene amplifying a 1409-bp fragment provided the target for PCR/RFLP analysis for species differentiation in the genus Avipoxvirus. The core protein gene is 1,971 nucleotides long, encoding a 75.2-kD protein; 1 it is one of the major polypeptides, accounting for approximately 11% of viral protein and is conserved among the members of Avipoxvirus. 1 The results of the study suggest that RFLP analyses of the 1409-bp product is a specific and reliable method for characterizing avian poxviruses. The core protein gene-defined PCR could also be useful in the rapid and sensitive identification of avian poxviruses in tissues of infected flocks and in the evaluation of avian vaccine poxviruses. Furthermore, species-specific detection of Avipoxvirus has specific application to pre-ventive situations in which detection would indicate whether a new species has emerged as the cause of continued disease and mortality in a vaccinated flock. Further studies are in progress to determine ways in which a PCR strategy could be devised for distinguishing between strains of FPV.
In conclusion, both RFLP and IB accurately distinguished vaccine strains and field isolates of FPV. Furthermore, amplification of a 4b core protein gene demonstrates the applicability of PCR for rapid identification and differentiation of the avian poxviruses.
